Search for a trial

A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the CNS Effects of Single and Multiple Doses of CST-101, CST-103, and CST-109 in Healthy Subjects and Patients with Parkinson*s Disease

The primary objectives of this study are:Part A 1. To characterize the effects of single doses of beta-adrenoceptor (β-AR) agonists CST-101, CST-103 and β AR partial agonist CST-109 on the functional domains of the central nervous system (CNS), as…